BGI Executive and Leadership Team

Allison Huang, the 經理，CEO助理 at BGI, supports executive leadership in strategic initiatives and operational coordination. This role involves facilitating communication between the CEO's office and various departments, ensuring efficient workflow and timely execution of directives. Huang contributes to the company's mission of making genomics accessible by streamlining internal processes and supporting high-level decision-making. The focus remains on enhancing operational efficiency and supporting the strategic goals of BGI. This involves managing administrative functions critical to the CEO's effectiveness and contributing to the overall accessibility of advanced genomics technologies.

Du Yutao, the Chief Operating Officer at BGI, directs all aspects of the company's operational infrastructure and execution. This leadership position involves overseeing the integration of BGI's broad array of leading genomics technologies, ensuring seamless deployment across research and clinical markets. Du Yutao drives efficiency in production, supply chain management, and service delivery, directly supporting the goal of making state-of-the-art genomics highly accessible globally. The operational strategy focuses on scaling BGI's capabilities to meet increasing demand from the research community and clinical practitioners. Du Yutao ensures that the company's operational framework aligns with its mission to democratize genomic technologies and expand market reach.

Hongsheng Liang, the President, , Southern & Middle (Asia Pacific, Asia, East) at BGI, spearheads regional growth and market penetration across key Asian territories. This executive role involves developing and executing strategies to expand BGI's footprint in the Asia Pacific, Asia, and East regions, making advanced genomics technologies more accessible to local research and clinical communities. Hongsheng Liang oversees regional sales, business development, and operational alignment, ensuring BGI's integrated technologies meet diverse market needs. The focus is on driving adoption of BGI's genomics solutions and fostering strong relationships with stakeholders throughout these critical markets. Liang's leadership ensures robust regional performance and contributes significantly to BGI's global accessibility mission.

Xu Xun, the President at BGI, provides overarching strategic direction and leadership for the company's global operations. This critical role involves guiding BGI's mission to make state-of-the-art genomics highly accessible, driving innovation across its broad array of leading technologies. Xu Xun focuses on fostering a culture of scientific advancement and operational excellence, ensuring BGI remains at the forefront of the genomics industry. The strategic vision encompasses expanding BGI's reach into new research and clinical markets, enhancing service delivery, and solidifying its position as a global leader. Xu Xun's leadership ensures the company's continued growth and impact in democratizing genomic insights worldwide.

Li Li, the Assitant President at BGI, supports the President in executing strategic initiatives and managing key operational areas. This role is integral to ensuring BGI's commitment to making state-of-the-art genomics highly accessible to global research and clinical markets. Li Li assists in coordinating cross-functional efforts, facilitating the integration of BGI's broad array of leading technologies. The focus is on enhancing operational efficiency and supporting the strategic expansion of BGI's services. Li Li contributes to maintaining strong relationships with partners and stakeholders, ensuring the smooth implementation of BGI's mission. This support function is vital for driving BGI's continued success in the genomics landscape.